Cystic Fibrosis Plasma Blunts the Immune Response to Bacterial Infection-Reference-Cited by-同舟云学术

Cystic Fibrosis Plasma Blunts the Immune Response to Bacterial Infection

Published:2019-09 Issue:3 Volume:61 Page:301-311
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Zhang Xi¹²³^ORCID,Pan Amy⁴⁵,Jia Shuang⁶⁷,Ideozu Justin E.¹²³,Woods Katherine⁸,Murkowski Kathleen⁸,Hessner Martin J.⁴⁶⁷,Simpson Pippa M.⁴⁵,Levy Hara¹²³^ORCID

Affiliation:

1. Division of Pulmonary Medicine, Department of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois

2. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois

3. Human Molecular Genetics Program, Stanley Manne Children’s Research Institute of Chicago, Chicago, Illinois

4. Children’s Research Institute of the Children’s Hospital of Wisconsin, Wauwatosa, Wisconsin; and

5. Division of Quantitative Health Sciences, Department of Pediatrics

6. Division of Endocrinology, Department of Pediatrics

7. Department of Pediatrics, Max McGee National Research Center for Juvenile Diabetes, and

8. Division of Pediatric Critical Care Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.atsjournals.org/doi/pdf/10.1165/rcmb.2018-0114OC

Reference51 articles.

1. Cystic fibrosis

2. Current Concepts and Controversies in Innate Immunity of Cystic Fibrosis Lung Disease

3. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis

4. Immune Responses in Cystic Fibrosis

5. Immunomodulatory Cell Therapy to Target Cystic Fibrosis Inflammation

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer;Cancer Cell International;2024-06-29

2. Unravelling the “frequent exacerbator” phenotype in cystic fibrosis;European Respiratory Journal;2024-02

3. Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy;The Lancet Respiratory Medicine;2023-10

4. The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation;Clinics in Chest Medicine;2022-12

5. A Splice Switch in SIGIRR Causes a Defect of IL-37-Dependent Anti-Inflammatory Activity in Cystic Fibrosis Airway Epithelial Cells;International Journal of Molecular Sciences;2022-07-13